🔎 Trials Near Me

Akèy › Obèsite › Minnesota › Minneapolis

Etid klinik pou Obèsite nan Minneapolis, MN

13 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Minneapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Ap rekriteFaz 3
  • International Diabetes Center, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07533175

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Ap rekriteFaz 3
  • International Diabetes Center, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07564414

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Ap rekriteFaz 3
  • University of Minnesota, Minneapolis
Laj 8 a 18 · Tout sèks · Mizajou Sep 30, 2026 · NCT07253285

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Ap rekriteFaz 3
  • University of Minnesota Masonic Children's Hospital, Minneapolis
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Minneapolis Heart Institute Foundation, Minneapolis
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • University of Minnesota, Minneapolis
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • International Diabetes Center At Park Nicollet, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, Minneapolis
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity

Ap rekrite
  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Laj 18 a 80 · Tout sèks · Mizajou Sep 8, 2026 · NCT05225233

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ap rekriteFaz 2
  • Children's Hospitals and Clinics of Minnesota, Minneapolis
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519

A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity

Ap rekriteFaz 4
  • Clinical Research Institute of Minnesota, Minneapolis
Laj 18 a 65 · Tout sèks · Mizajou Jul 27, 2026 · NCT07728383

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Ap rekrite
  • Minneapolis VA Health Care System, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT06390345

Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults

Ap rekriteFaz 1/2
  • University of Minnesota, Minneapolis
Laj 21 a 75 · Tout sèks · Mizajou Dec 17, 2025 · NCT06226077

Etid Obèsite nan lòt vil

Lòt etid nan Minneapolis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.